Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
VICKI A MORRISON
Listed Specialty: Hematology & Oncology
701 PARK AVE, HCMC, HEMATOLOGY ONCOLOGY DIVISION, MAIL CODE O1, MINNEAPOLIS, MN, 55415-1623
DR. VICKI MORRISON,
Yearly Payment Breakdown:
2018 Payments At a Glance
91
payments
$91,919
payment total
8
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
Category | Payments | Payment Value |
---|---|---|
Promotional Speaking/Other |
20 | $56,915 |
Consulting |
6 | $17,765 |
Travel and Lodging |
42 | $15,969 |
Food and Beverage |
21 | $1,180 |
Education |
2 | $90 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
Product Name | Product Type | Payments† |
---|---|---|
REVLIMID |
drug |
$25,611 |
VENCLEXTA |
drug |
$21,831 |
IMBRUVICA |
drug |
$14,197 |
GAZYVA |
drug |
$10,969 |
NINLARO |
drug |
$6,000 |
ADCETRIS |
drug |
$5,924 |
Payments with no listed product |
N/A |
$5,403 |
ALIQOPA |
drug |
$1,893 |
ONIVYDE |
drug |
$90 |
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. |
Payment Details in 2018
When | How Much | Related To | What For | From | Third Party Payee |
---|---|---|---|---|---|
Dec 20, 2018 | $6,475 | REVLIMID | Consulting | CELGENE CORPORATION | |
Mar 31, 2018 | $4,500 | NINLARO | Consulting | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Oct 15, 2018 | $4,160 | GAZYVA | Promotional Speaking/Other | GENENTECH USA, INC. | |
Apr 25, 2018 | $4,160 | VENCLEXTA | Promotional Speaking/Other | GENENTECH USA, INC. | |
Jul 19, 2018 | $4,160 | GAZYVA | Promotional Speaking/Other | GENENTECH USA, INC. | |
Oct 18, 2018 | $4,160 | VENCLEXTA | Promotional Speaking/Other | GENENTECH USA, INC. | |
Oct 25, 2018 | $4,160 | No Listed Product | Promotional Speaking/Other | GENENTECH USA, INC. | |
Aug 23, 2018 | $4,160 | VENCLEXTA | Promotional Speaking/Other | GENENTECH USA, INC. | |
Sep 5, 2018 | $4,160 | VENCLEXTA | Promotional Speaking/Other | GENENTECH USA, INC. | |
Jul 6, 2018 | $3,850 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Jun 20, 2018 | $3,800 | IMBRUVICA | Promotional Speaking/Other | JANSSEN BIOTECH, INC. | |
May 19, 2018 | $3,800 | IMBRUVICA | Promotional Speaking/Other | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Oct 18, 2018 | $3,600 | ADCETRIS | Promotional Speaking/Other | SEATTLE GENETICS, INC. | |
Apr 9, 2018 | $3,000 | IMBRUVICA | Consulting | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Sep 26, 2018 | $2,695 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Sep 26, 2018 | $2,625 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Jul 6, 2018 | $2,625 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Jun 1, 2018 | $1,710 | ALIQOPA | Consulting | BAYER HEALTHCARE PHARMACEUTICALS INC. | |
Oct 15, 2018 | $1,633 | GAZYVA | Travel and Lodging | GENENTECH USA, INC. | |
Jun 8, 2018 | $1,500 | NINLARO | Consulting | TAKEDA PHARMACEUTICALS U.S.A., INC. | |
Jul 6, 2018 | $1,353 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Sep 24, 2018 | $1,200 | ADCETRIS | Promotional Speaking/Other | SEATTLE GENETICS, INC. | |
Sep 5, 2018 | $1,026 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Jan 19, 2018 | $1,000 | ADCETRIS | Promotional Speaking/Other | SEATTLE GENETICS, INC. | |
May 19, 2018 | $952 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Oct 18, 2018 | $907 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Oct 25, 2018 | $880 | No Listed Product | Travel and Lodging | GENENTECH USA, INC. | |
Sep 26, 2018 | $851 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Sep 26, 2018 | $843 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Aug 23, 2018 | $836 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Feb 20, 2018 | $750 | REVLIMID | Promotional Speaking/Other | CELGENE CORPORATION | |
Sep 17, 2018 | $750 | IMBRUVICA | Promotional Speaking/Other | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Jul 6, 2018 | $701 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Dec 20, 2018 | $580 | REVLIMID | Consulting | CELGENE CORPORATION | |
Jan 18, 2018 | $550 | GAZYVA | Promotional Speaking/Other | GENENTECH USA, INC. | |
May 22, 2018 | $550 | VENCLEXTA | Promotional Speaking/Other | GENENTECH USA, INC. | |
May 19, 2018 | $540 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Nov 8, 2018 | $504 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Mar 22, 2018 | $434 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Sep 26, 2018 | $434 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
May 17, 2018 | $359 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Jul 6, 2018 | $285 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Nov 8, 2018 | $273 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Sep 5, 2018 | $262 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Oct 18, 2018 | $238 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Jul 19, 2018 | $204 | GAZYVA | Travel and Lodging | GENENTECH USA, INC. | |
Apr 25, 2018 | $201 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Mar 23, 2018 | $200 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Aug 23, 2018 | $189 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Oct 25, 2018 | $158 | No Listed Product | Travel and Lodging | GENENTECH USA, INC. | |
Dec 20, 2018 | $131 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Nov 8, 2018 | $129 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Oct 18, 2018 | $127 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Oct 15, 2018 | $127 | GAZYVA | Travel and Lodging | GENENTECH USA, INC. | |
Oct 25, 2018 | $126 | No Listed Product | Travel and Lodging | GENENTECH USA, INC. | |
May 19, 2018 | $125 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Jun 1, 2018 | $125 | ALIQOPA | Food and Beverage | BAYER HEALTHCARE PHARMACEUTICALS INC. | |
Sep 5, 2018 | $125 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Sep 26, 2018 | $125 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Aug 23, 2018 | $125 | VENCLEXTA | Travel and Lodging | GENENTECH USA, INC. | |
Nov 8, 2018 | $125 | REVLIMID | Food and Beverage | CELGENE CORPORATION | |
Jul 6, 2018 | $123 | REVLIMID | Travel and Lodging | CELGENE CORPORATION | |
Jan 19, 2018 | $118 | ADCETRIS | Food and Beverage | SEATTLE GENETICS, INC. | |
Oct 25, 2018 | $79 | No Listed Product | Food and Beverage | GENENTECH USA, INC. | |
Mar 22, 2018 | $78 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
May 19, 2018 | $74 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Jul 19, 2018 | $73 | GAZYVA | Food and Beverage | GENENTECH USA, INC. | |
Oct 18, 2018 | $71 | VENCLEXTA | Food and Beverage | GENENTECH USA, INC. | |
Sep 5, 2018 | $70 | VENCLEXTA | Food and Beverage | GENENTECH USA, INC. | |
Apr 9, 2018 | $63 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
May 19, 2018 | $62 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Apr 9, 2018 | $62 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Jul 6, 2018 | $58 | REVLIMID | Food and Beverage | CELGENE CORPORATION | |
Aug 23, 2018 | $54 | VENCLEXTA | Food and Beverage | GENENTECH USA, INC. | |
Mar 23, 2018 | $52 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Jul 19, 2018 | $50 | GAZYVA | Food and Beverage | GENENTECH USA, INC. | |
Apr 25, 2018 | $49 | VENCLEXTA | Food and Beverage | GENENTECH USA, INC. | |
May 14, 2018 | $47 | ONIVYDE | Education | IPSEN BIOPHARMACEUTICALS, INC | |
May 19, 2018 | $46 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Sep 26, 2018 | $45 | REVLIMID | Food and Beverage | CELGENE CORPORATION | |
May 19, 2018 | $43 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Jun 1, 2018 | $43 | ALIQOPA | Travel and Lodging | BAYER HEALTHCARE PHARMACEUTICALS INC. | |
May 14, 2018 | $43 | ONIVYDE | Education | IPSEN BIOPHARMACEUTICALS, INC | |
Mar 23, 2018 | $42 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
May 19, 2018 | $37 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Sep 26, 2018 | $30 | REVLIMID | Food and Beverage | CELGENE CORPORATION | |
May 19, 2018 | $24 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Jun 1, 2018 | $15 | ALIQOPA | Food and Beverage | BAYER HEALTHCARE PHARMACEUTICALS INC. | |
Oct 15, 2018 | $13 | GAZYVA | Food and Beverage | GENENTECH USA, INC. | |
Mar 22, 2018 | $12 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
Jan 19, 2018 | $6 | ADCETRIS | Travel and Lodging | SEATTLE GENETICS, INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.